Elisa Lee to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Elisa Lee has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.033
-
OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review. Aesthet Surg J. 2016 May; 36(5):591-7.
Score: 0.033